<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Revive Therapeutics Provides Update on Phase III Trials
Image Overlay - Revive Therapeutics Provides Update on Phase III Trials

Revive Therapeutics Provides Update on Phase III Trials

Revive Therapeutics Provides Update on Phase III Trials

Revive Therapeutics Ltd., a life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is proceeding with a phase III clinical trial of Bucillamine in patients with mild-moderate COVID-19 following FDA approval. Revive expects trials to take place in up to 10 clinical trial sites across the U.S.; patient screening will begin in Q3. Yourway is headquartered Allentown, Pennsylvania – with a reliable transportation network, we are able to make deliveries across the country (and around the world) within hours, not days.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?